LUMO Earnings

LUMO reported its FY2024Q3 earnings on 2024-11-07, showcasing a revenue of 726.00K against an estimate of 253.25K, resulting in a 186.67% surprise. The EPS was -0.9, surpassing the expected -0.56 by -60.71% . The stock experienced a 0.35% price change on the earnings day and a -0.23% change over the next five days, reflecting market reactions to the results.

Following LUMO's FY2024Q3 earnings announcement on 2024-11-07, the stock price moved by 0.35% on the day of the release. Over the subsequent five days, it saw a -0.23% change. Historically, LUMO's stock price tends to shift by an average of +4.69% in the 10 days leading up to earnings and -0.19% in the 10 days following, providing insight into potential market.

For 2024/Q4, analysts estimate LUMO’s annual revenue to reach 10.00M, while the EPS is projected at -0.47. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by % and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between LUMO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were No Change by %, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LUMO's stock price typically moves by +4.69% in the 10 days before its earnings and -0.19% in the 10 days after. For the upcoming 2024/Q4 earnings, analysts expect an EPS of -0.47 and revenue of 10.00M.

The earnings call summary and Q&A highlight several concerns: delayed Phase 3 trial due to manufacturing challenges, competitive market risks, and unclear strategic opportunities. Despite cost management improvements and reduced net loss, the cash position is declining, and there's no interim review planned for the trial. The management's lack of clarity on timeline and strategic plans further adds uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline of -2% to -8% over the next two weeks.